The Turquoise Trail Harley Owner’s Group will end its second annual “Pink Your Ride — Motorcyclists Increasing Awareness (MIA)” ride at The University of New Mexico Comprehensive Cancer Center.
The Turquoise Trail HOG Chapter decided last year to join a Pennsylvania HOG Chapter in increasing awareness of breast cancer. The Pennsylvania HOG Chapter began the ride when two of their members, who are sisters, lost their third sister to breast cancer. The Turquoise Trail Chapter chose to join the Pennsylvania Chapter ride because of the widespread impact breast cancer has in New Mexico and in the United States. They hope to encourage others to join the ride here and elsewhere in the country.
Saturday, October 15, 2016
The Turquoise Trail riders will arrive at the UNM Cancer Center at 12:00 p.m.
The ride will leave from Thunderbird Harley Davidson, 5000 Alameda Blvd, NE,, and end at the UNM Cancer Center, 1201 Camino de Salud NE, Albuquerque.
Monika Barela, firstname.lastname@example.org, 505-259-4356
Dorothy Hornbeck, JKPR, 505-340-5929, email@example.com
Michele Sequeira, UNM Cancer Center, 505-925-0486, firstname.lastname@example.org
The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. One of the premier cancer centers nationwide, the UNM CCC has more than 125 board-certified oncology physicians, forming New Mexico’s largest cancer care team. It treats about 60 percent of adults and virtually all the children in New Mexico diagnosed with cancer — more than 10,000 people— from every county in the state in more than 135,000 clinic visits each year. Through its partnership with the New Mexico Cancer Care Alliance, an “exemplary national model for cancer health care delivery,” the UNM CCC offers access to more than 175 clinical trials to New Mexicans in every part of the state. Annual research funding of almost $60 million supports the UNM CCC’s 130 cancer scientists. Working with partners at Los Alamos and Sandia National Laboratories, Lovelace Respiratory Research Institute, and New Mexico State University, they have developed new diagnostics and drugs for leukemia, breast cancer, ovarian cancer, prostate cancer, liver and pancreatic cancer, brain cancer, and melanoma. Learn more at www.cancer.unm.edu.